MedPath

USANA ANTICAVITY TREATMENT GEL

USANA ANTICAVITY TREATMENT GEL

Discontinued
DIN Number

02237647

Drug Class

Human

Market Date

Jul 27, 1998

Company
HC

usana health sciences inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02237647
AIG Number0107084002
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A01AA04 STANNOUS FLUORIDE
Product Specifications
Dosage FormGel
Route of AdministrationOral
AHFS Classification34:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

STANNOUS FLUORIDEActive
Strength: 0.4 %
Monograph: STANNOUS FLUORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.